Pavel F. Pavlov

The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.

Mitochondrial accumulation of APP and Abeta: significance for Alzheimer disease pathogenesis.

Association of Omi/HtrA2 with γ-secretase in mitochondria.

Mitochondrial γ-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein.

Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.

Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.

Combined x-ray crystallography and computational modeling approach to investigate the Hsp90 C-terminal peptide binding to FKBP51.

Development of GMP-1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's disease.

identification and biochemical characterization of the human dicarboxylate clamp TPR protein interaction network.

Metal Binding by GMP-1 and Its Pyrimido [1, 2]benzimidazole Analogs Confirms Protection Against Amyloid-β Associated Neurotoxicity.

Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.